| Business Name: |
Uju Akabogu Melissa MD |
| Contact Person: |
Melissa Uju Akabogu |
| Address: |
4170 Pennsylvania Avenue, Dubuque, Iowa 52002 |
| Phone Number: |
(563) 588-0011 |
| Website Address: |
womenswellnessdbq.com |
| Annual Revenue (USD): |
$100.000 to $499.999 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Doctors |
| SIC Code: |
8011 |
| NAICS Code: |
6211110 |
| Share This Business: |
|
| Related Businesses: |
Mulderig Peggy MD - Dubuque, IA 52002
Field David MD - Dubuque, IA 52002
Niemer Mark W MD - Dubuque, IA 52002
Chapman Michael P MD - Dubuque, IA 52002
Alexander Terence A MD - Dubuque, IA 52002
Mullen Kevin MD - Dubuque, IA 52002
Hubbard James R MD - Dubuque, IA 52002
Fuerste Gretchen MD - Dubuque, IA 52002
Mc Climon Brad MD - Dubuque, IA 52002
Maiers Timothy MD - Dubuque, IA 52002
Buckley Krynn MD - Dubuque, IA 52002
Hartmann John DO - Dubuque, IA 52002
Moore Mark P MD - Dubuque, IA 52002
Tinsman Peter W MD - Dubuque, IA 52002
Sakas Peter B MD - Dubuque, IA 52002
Fuerste C Rommel MD - Dubuque, IA 52002
Kim Howard T MD - Dubuque, IA 52002
Dubuque Rheumatology Pc - Dubuque, IA 52002
Daoud Diana S MD - Dubuque, IA 52002
Walker Marian DO - Dubuque, IA 52002
|
The company Uju Akabogu Melissa MD provides B2C services in the form of Doctors from its single location in Iowa.
1 to 4 employees work for Uju Akabogu Melissa MD, and the business now earns $100.000 to $499.999 per annum.
Uju Akabogu Melissa MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Uju Akabogu Melissa MD, please call Melissa Uju Akabogu with the phone number (563) 588-0011 or visit its single location at 4170 Pennsylvania Avenue in Dubuque, Iowa 52002.
The location of the single location can also be found using the coordinates 42.50051,-90.74853.
Read more details about this business on the webpage womenswellnessdbq.com or follow the company’s social media accounts, on Twitter and on Facebook.